How can we improve the performance of Model for End-Stage Liver Disease sodium score in patients with hepatitis B virus-related decompensated liver cirrhosis commencing antiviral treatment?-Reference-Cited by-同舟云学术

How can we improve the performance of Model for End-Stage Liver Disease sodium score in patients with hepatitis B virus-related decompensated liver cirrhosis commencing antiviral treatment?

Published:2018-03-22 Issue:9 Volume:33 Page:1641-1648
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Kim Tae Hyung¹^ORCID,Ku Dae Hoe¹,Um Soon Ho¹,Lee Han Ah¹,Park Seung Woon¹,Chang Jung Mi¹,Yim Sun Young¹,Suh Sang Jun¹,Jung Young Kul¹^ORCID,Seo Yeon Seok¹,Kim Ji Hoon¹,Yim Hyung Joon¹,Yeon Jong Eun¹,Byun Kwan Soo¹,Ahn Hyonggin²

Affiliation:

1. Department of Internal Medicine; Korea University College of Medicine; Seoul Korea

2. Department of Medical Statistics; Korea University College of Medicine; Seoul Korea

Funder

Korea Healthcare Technology R&D project

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.14128/fullpdf

Reference27 articles.

1. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version);EASL International Consensus Conference on Hepatitis B;J. Hepatol.,2003

2. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity;Ott;Vaccine,2012

3. More than third of world's population has been infected with hepatitis B virus;Zuckerman;BMJ,1999

4. Current status of liver diseases in Korea: hepatitis B;Chae;Korean J. Hepatol.,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of HCC decreases in HBV-related patients with cirrhosis acquired recompensation: A retrospective study based on Baveno VII criteria;Hepatology Communications;2023-12-22

2. New prognostic model for hospitalized patients with alcoholic cirrhosis and Maddrey’s discriminant function <32;Hepatology International;2023-10-13

3. Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy;Frontiers in Cellular and Infection Microbiology;2023-01-12

4. Determinants of re‐compensation in patients with hepatitis B virus‐related decompensated cirrhosis starting antiviral therapy;Alimentary Pharmacology & Therapeutics;2021-10-18

5. Clinical implications of thoracic duct dilatation in patients with chronic liver disease;Medicine;2020-05-29